These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31068081)

  • 1. Classifying intracranial stenosis disease severity from functional MRI data using machine learning.
    Waddle SL; Juttukonda MR; Lants SK; Davis LT; Chitale R; Fusco MR; Jordan LC; Donahue MJ
    J Cereb Blood Flow Metab; 2020 Apr; 40(4):705-719. PubMed ID: 31068081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior Infarcts, Reactivity, and Angiography in Moyamoya Disease (PIRAMD): a scoring system for moyamoya severity based on multimodal hemodynamic imaging.
    Ladner TR; Donahue MJ; Arteaga DF; Faraco CC; Roach BA; Davis LT; Jordan LC; Froehler MT; Strother MK
    J Neurosurg; 2017 Feb; 126(2):495-503. PubMed ID: 26967789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide.
    Federau C; Christensen S; Zun Z; Park SW; Ni W; Moseley M; Zaharchuk G
    Neuroradiology; 2017 Jan; 59(1):5-12. PubMed ID: 27913820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CBF Measured with Combined Velocity-Selective Arterial Spin-Labeling and Pulsed Arterial Spin-Labeling to Blood Flow Patterns Assessed by Conventional Angiography in Pediatric Moyamoya.
    Bolar DS; Gagoski B; Orbach DB; Smith E; Adalsteinsson E; Rosen BR; Grant PE; Robertson RL
    AJNR Am J Neuroradiol; 2019 Nov; 40(11):1842-1849. PubMed ID: 31694821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary and emerging magnetic resonance imaging methods for evaluation of moyamoya disease.
    Lehman VT; Cogswell PM; Rinaldo L; Brinjikji W; Huston J; Klaas JP; Lanzino G
    Neurosurg Focus; 2019 Dec; 47(6):E6. PubMed ID: 31786551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Intravascular Signal Arterial Transit Time Artifacts Have Negligible Effects on Cerebral Blood Flow and Cerebrovascular Reserve Capacity Measurement Using Single Postlabel Delay Arterial Spin-Labeling in Patients with Moyamoya Disease.
    Fahlström M; Lewén A; Enblad P; Larsson EM; Wikström J
    AJNR Am J Neuroradiol; 2020 Mar; 41(3):430-436. PubMed ID: 32115416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease.
    Ishii Y; Thamm T; Guo J; Khalighi MM; Wardak M; Holley D; Gandhi H; Park JH; Shen B; Steinberg GK; Chin FT; Zaharchuk G; Fan AP
    J Magn Reson Imaging; 2020 Jan; 51(1):183-194. PubMed ID: 31044459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 7.0- and 3.0-T MRI and MRA in ischemic-type moyamoya disease: preliminary experience.
    Deng X; Zhang Z; Zhang Y; Zhang D; Wang R; Ye X; Xu L; Wang B; Wang K; Zhao J
    J Neurosurg; 2016 Jun; 124(6):1716-25. PubMed ID: 26544772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Planning-free cerebral blood flow territory mapping in patients with intracranial arterial stenosis.
    Arteaga DF; Strother MK; Davis LT; Fusco MR; Faraco CC; Roach BA; Scott AO; Donahue MJ
    J Cereb Blood Flow Metab; 2017 Jun; 37(6):1944-1958. PubMed ID: 27389177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting PET Cerebrovascular Reserve with Deep Learning by Using Baseline MRI: A Pilot Investigation of a Drug-Free Brain Stress Test.
    Chen DYT; Ishii Y; Fan AP; Guo J; Zhao MY; Steinberg GK; Zaharchuk G
    Radiology; 2020 Sep; 296(3):627-637. PubMed ID: 32662761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Support vector machine learning-based cerebral blood flow quantification for arterial spin labeling MRI.
    Wang Z
    Hum Brain Mapp; 2014 Jul; 35(7):2869-75. PubMed ID: 24443217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of vessel wall lesions and vascular stenoses on cerebrovascular reactivity in patients with intracranial stenotic disease.
    Cogswell PM; Davis TL; Strother MK; Faraco CC; Scott AO; Jordan LC; Fusco MR; Frederick BD; Hendrikse J; Donahue MJ
    J Magn Reson Imaging; 2017 Oct; 46(4):1167-1176. PubMed ID: 28061015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-contrast hemodynamic imaging of Moyamoya disease with MR fingerprinting ASL: A feasibility study.
    Su P; Liu P; Pinho MC; Thomas BP; Qiao Y; Huang J; Welch BG; Lu H
    Magn Reson Imaging; 2022 May; 88():116-122. PubMed ID: 35183659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET.
    Goetti R; Warnock G; Kuhn FP; Guggenberger R; O'Gorman R; Buck A; Khan N; Scheer I
    AJNR Am J Neuroradiol; 2014 May; 35(5):1022-8. PubMed ID: 24335546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between hypercarbic reactivity, cerebral blood flow, and arterial circulation times in patients with moyamoya disease.
    Donahue MJ; Ayad M; Moore R; van Osch M; Singer R; Clemmons P; Strother M
    J Magn Reson Imaging; 2013 Nov; 38(5):1129-39. PubMed ID: 23440909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine clinical evaluation of cerebrovascular reserve capacity using carbogen in patients with intracranial stenosis.
    Donahue MJ; Dethrage LM; Faraco CC; Jordan LC; Clemmons P; Singer R; Mocco J; Shyr Y; Desai A; O'Duffy A; Riebau D; Hermann L; Connors J; Kirshner H; Strother MK
    Stroke; 2014 Aug; 45(8):2335-41. PubMed ID: 24938845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged Mean Transit Time Detected by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Predicts Cerebrovascular Reserve Impairment in Patients with Moyamoya Disease.
    Kawano T; Ohmori Y; Kaku Y; Muta D; Uekawa K; Nakagawa T; Amadatsu T; Kasamo D; Shiraishi S; Kitajima M; Kuratsu J
    Cerebrovasc Dis; 2016; 42(1-2):131-8. PubMed ID: 27088711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial transit artifacts observed by arterial spin labeling in Moyamoya disease.
    Ukai R; Mikami T; Nagahama H; Wanibuchi M; Akiyama Y; Miyata K; Mikuni N
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105058. PubMed ID: 32807463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual echo vessel-encoded ASL for simultaneous BOLD and CBF reactivity assessment in patients with ischemic cerebrovascular disease.
    Faraco CC; Strother MK; Dethrage LM; Jordan L; Singer R; Clemmons PF; Donahue MJ
    Magn Reson Med; 2015 Apr; 73(4):1579-92. PubMed ID: 24757044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring Cerebrovascular Reactivity through the Use of Arterial Spin Labeling in Patients with Moyamoya Disease.
    Yun TJ; Paeng JC; Sohn CH; Kim JE; Kang HS; Yoon BW; Choi SH; Kim JH; Lee HY; Han MH; Zaharchuk G
    Radiology; 2016 Jan; 278(1):205-13. PubMed ID: 26197057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.